A systematic overview of the medicinal importance of sanguivorous leeches

Alternative Medicine Review

Volumn 16, Issue 1, 2011, Pages 59-65

  Abbas Zaidi, S M ^a   Jameel, S S ^b,c   Zaman, F ^c   Jilani, Shazia ^c   Sultana, A ^c   Khan, Shariq A ^d  

^a HSZH Government Unani Medical College   (India)

^b Central Council for Research in Unani Medicine   (India)

^c HAMDARD UNIVERSITY   (India)

^d CCRUM   (India)

Author keywords

Amputate; Amputation; Annelid; Anticoagulant; Antithrombotic; Blood sucking; Hirudin; Hirudo; Hirudo medicinalis; Leech; Leech saliva; Leeches; Sanguivorous; Thrombolytic

Indexed keywords

ANTICOAGULANT AGENT; APYRASE; BDELLIN; CALIN; DECORSIN; DESTABILASE; EGLIN C; GAMMA GLUTAMYLTRANSFERASE; GELIN; GUAMERIN; HIRUDIN; HIRUSTASIN; HYALURONIDASE; PIGUAMERIN; PLASMIN; RECOMBINANT HIRUDIN; THROMBIN; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ANNELID WORM; ANTITHROMBIN DEFICIENCY; ARTERY THROMBOSIS; DEEP VEIN THROMBOSIS; DRUG ISOLATION; DRUG SCREENING; EMPHYSEMA; FIBRINOLYSIS; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEART INFARCTION; HIRUDO MANILLENSIS; HUMAN; LEECH; LEECHING; NONHUMAN; REVIEW; SALIVA; SHOCK; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA; VENOUS THROMBOEMBOLISM;

EID: 83455262905     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (82)

1. Anonymous. The Wealth of India. New Delhi, India: Council of Scientific and Industrial Research YNM; 1996:VI(L-M).
2. Bhatia ML. Hirudinaria (The Indian Cattle Leech). Lucknow, India: Indian Zoological Memoirs; 1941.
3. Sawyer RT. Leech Biology and Behaviour. Oxford, UK: Oxford University Press; 1986.
4. Apakupakul K, Siddall ME, Burreson EM. Higher level relationships of leeches (Annelida: Clitellata: Euhirudinea) based on morphology and gene sequences. Mol Phylogenet Evol 1999;12:350-359. (Pubitemid 129499313)
5. Munro R, Siddall M, Desserts SS, Sawyer RT. Bleeding in human volunteers from the bite of the American medicinal leech Macrobdella decora compared with its European counterpart Hirudo medicinalis. Comp Hematol Int 1991;1:214-216.
6. Jung HI, Kim SI, Ha KS, et al. Isolation and characterization of Guamerin, a new human leucocyte elastase inhibitor from Hirudo nipponia. J Biol Chem 1995;270:13879-13884.
7. Van Wingerden JJ, Oosthuizen JH. Use of the local leech Hirudo michaelseni in reconstructive plastic and hand surgery. S Afr J Surg 1997;35:29-31. (Pubitemid 27197474)
8. Philips AJ, Siddall ME. Phylogeny of new world medicinal leech family Macrobdellidae (Oligochaeta: Hirudinida: Arynchobdellida). Zool Scr 2005;34:559-564. (Pubitemid 41780384)
9. Baskova IP, Kostrjukova ES, Vlasova MA, et al. Proteins and peptides of the salivary gland secretion of medicinal leeches Hirudo verbena, H. medicinalis, and H. orientalis. Biochemistry (Mosc) 2008;73:315-320. (Pubitemid 351490981)
10. Adams SL. The medicinal leech. A page from the annelids of internal medicine. Ann Intern Med 1988;109:399-405.
11. Bates M, Kneer K, Logan C. Medicinal leech therapy: an overview (continuing education credit). Orthop Nurs 1989;8:12-17.
12. Engemann JF, Hegner RW. Phylum annelida, class III: Hirudo medicinalis, the medicinal leech. Invertebrate Zoology. 3rd edition. New York. NY: McMillan; 1981:420-426.
13. Bodong A. Uber Hirushin. Arch Exp Pathol Pharmacol 1905;52:242-261. [Article in German]
14. Markwardt F. Untersuchunjen uber hirudin. Naturwissenschaften 1955;42:537-538. [Article in German]
15. Electricwala A, Sawyer RT, Jones CP, Atkinson T. Isolation of thrombin inhibitor from the leech Hirudinaria manillensis. Blood Coagul Fibrinolysis 1991;2:83-89.
16. Electricwala A, Hartwell R, Scawen MD, Atkinson T. The complete amino acid sequence of a hirudin variant from the leech Hirudinaria manillensis. J Protein Chem 1993;12:365-370. (Pubitemid 23213756)
17. Electricwala A, von Sicard NA, Sawyer RT, Atkinson T. Biochemical characterisation of a pancreatic elastase inhibitor from the leech Hirudinaria manillensis. J Enzyme Inhib 1992;6:293-302. (Pubitemid 23170838)
18. Scacheri E, Nitti G, Valsasina B, et al. Novel hirudin variants from the leech Hirudinaria manillensis. Amino acid sequence, cDNA cloning and genomic organization. Eur J Biochem 1993;214:295-304. (Pubitemid 23168546)
19. Bichler J, Fritz H. Hirudin, a new therapeutic tool? Ann Hematol 1991;63:67-76.
20. Field WS. The history of leeching and hirudin. Haemostasis 1991;21:3-10.
21. Walsmann P, Markwardt F. Biochemical and pharmacological aspects of the thrombin inhibitor hirudin. Pharmazie 1981;36:653-660. [Article in German] (Pubitemid 12211895)
22. Markwardt F. Studies on the mechanism of the anticoagulant effect of hirudin. Naunyn Schmiedebergs Arch Exp Phatol Pharmakol 1956;229:389-399. [Article in German]
23. No authors listed. Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial. Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators. Lancet 1999;353:429-438.
24. Badimon L, Meyer BJ, Badimon JJ. Thrombin in arterial thrombosis. Haemostasis 1994;24:69-80. (Pubitemid 24234485)
25. Chesebro JH, Fuster V. The therapeutic challenge of plaque rupture: value of biochemical markers. J Am Coll Cardiol 1987;10:1005.
26. Bar-Shavit R, Eldor A, Vlodavsky I. Binding of thrombin to subendothelial extracellular matrix. Protection and expression of functional properties. J Clin Invest 1989;84:1096-1104. (Pubitemid 19247578)
27. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A 1989;86:2839-2843. (Pubitemid 19112635)
28. Weitz JI, Hudoba M, Massel D, et al. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. J Clin Invest 1990;86:385-391. (Pubitemid 20271869)
29. Becker RC. Thrombin antagonists and antiplatelet agents. Am J Cardiol 1992;69:39A-51A.
30. Cannon CP, McCabe CH, Henry TD, et al. A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial. J Am Coll Cardiol 1994;23:993-1003. (Pubitemid 24117126)
31. Hirsh J. Heparin. N Eng J Med 1991;324:1565-1574.
32. Johnson PH. Hirudin: clinical potential of a thrombin inhibitor. Annu Rev Med 1994;45:165-177. (Pubitemid 24158153)
33. Michalsen A, Roth M, Dobos G, Aurich M. Medicinal Leech Therapy. Stuttgart, Germany: Thieme; 2007.
34. Linker A, Hoffman P, Meyer K. The hyaluronidase of the leech: an endoglucuronidase. Nature 1957;180:810-811.
35. Linker A, Meyer K, Hoffman P. The production of hyaluronate oligosaccharides by leech hyaluronidase and alkali. J Biol Chem 1960;235:924-927.
36. Menzel EJ, Farr C. Hyaluronidase and its substrate hyaluronan: biochemistry, biological activities and therapeutic uses. Cancer Lett 1998;131:3-11. (Pubitemid 28467035)
37. Frost G, Csoka T, Stern R. The hyaluronidases: a chemical, biological and clinical overview. Trends Glycosci Glycotechnol 1996;8:419-434.
38. Salzet M. Anticoagulants and inhibitors of platelet aggregation derived from leeches. FEBS Lett 2001;492:187-192. (Pubitemid 32217826)
39. Farr C, Menzel J, Seeberger J, Schweigle B. Clinical pharmacology and possible applications of hyaluronidase with reference to Hylase "Dessau". Wein Med Wochenschr 1997;147:347-355. (Article in German] (Pubitemid 27438305)
40. Hovingh P, Linker A. Hyaluronidase activity in leeches (Hirudinea). Comp Biochem Physiol B Biochem Mol Biol 1999;124:319-326. (Pubitemid 29502597)
41. Muckenschnabel I, Bernhardt G, Spruss T, Buschauer A. Hyaluronidase pretreatment produces selective melphalan enrichment in malignant melanoma implanted in nude mice. Cancer Chemother Pharmacol 1996;38:88-94.
42. Spruss T, Bernhardt G, Schonenberger H, Schiess W. Hyaluronidase significantly enhances the efficacy of regional vinblastine chemotherapy of malignant melanoma. J Cancer Res Clin Oncol 1995;121:193-202.
43. Munro R, Jones CP, Sawyer RT. Calin - a platelet adhesion inhibitor from the saliva of medicinal leech. Blood Coagul Fibrinolysis 1991;2:179-184.
44. Harsfalvi J, Stassen JM, Hoylaerts MF, et al. Calin from Hirudo medicinalis, an inhibitor of von Willebrand factor binding to collagen under static and flow conditions. Blood 1995;85:705-711.
45. Deckmyn H, Stassen JM, Vreys I, et al. Calin from Hirudo medicinalis, an inhibitor of platelet adhesion to collagen, prevents platelet-rich thrombosis in hamsters. Blood 1995;85:712-719.
46. Zavalova LL, Yudina TG, Artamonova II, Baskova IP. Antibacterial non-glycosidase activity of invertebrate destabilase-lysozyme and of its helical amphipathic peptides. Chemotherapy 2006;52:158-160. (Pubitemid 43760314)
47. Baskova IP, Zavalova LL. Polyfunctionality of lysozyme destabilase from the medicinal leech. Russ J Bioorganic Chem 2008;34:304-309.
48. Baskova IP, Nikonov GI. Destabilase, the novel epsilon-(gamma-Glu)-Lys isopeptidase with thrombolytic activity. Blood Coagul Fibrinolysis 1991;2:167-172.
49. Baskova IP, Nikonov GI. Destabilase: an enzyme of medicinal leech salivary gland secretion hydrolyzes the isopeptide bonds in stabilized fibrin. Biokhimiia 1985;50:424-431. [Article in Russian]
50. Nikonov GI, Titova EA. Destabilase complexes - natural liposome produced by medicinal leeches Hirudo medicinalis. Fundam Clin Pharmacol 1999;13:102-106.
51. Zavalova LL, Baskova IP, Lukyanov SA, et al. Destabilase from the medicinal leech is a representative of a novel family of lysozymes. Biochim Biophys Acta 2000;1478:69-77. (Pubitemid 30136140)
52. Rigbi M, Orevi M, Eldor A. Platelet aggregation and coagulation inhibitors in leech saliva and their roles in leech therapy. Semin Thromb Hemost 1996;22:273-278. (Pubitemid 26249134)
53. Rigbi M, Levy H, Iraqi F, et al. The saliva of the medicinal leech Hirudo medicinalis-I. Biochemical characterization of the high molecular weight fraction. Comp Biochem Physiol B 1987;87:567-573.
54. Seemuller U, Dodt J, Fink E, Fritz H. Proteinase inhibitors of the leech Hirudo medicinalis (hirudins, bdellins, eglins). In: Barettand AJ, Salvesen G, eds. Proteinase Inhibitors. New York, NY: Elsevier Science Ltd; 1986:337-359.
55. Ascenzi P, Aducci P, Amiconi G, et al. Binding of the recombinant proteinase inhibitor eglin c from leech Hirudo medicinalis to serine (pro)enzymes: a comparative thermodynamic study. J Mol Recognit 1991:4:113-119.
56. Seemuller U, Meier M, Ohlsson K, et al. Isolation and characterisation of a low molecular weight inhibitor (of chymotrypsin and human granulocyte elastase and cathepsin G) from leeches. Hoppe Seylers Z Physiol Chem 1977;358:1105-1107.
57. Braun NJ, Schnebli HP. A brief review of the biochemistry and pharmacology of Eglin c, an elastase inhibitor. Eur J Respir Dis Suppl 1986;146:541-547. (Pubitemid 17180242)
58. Jochum H, White J, Dusald KH, et al. Pathobiochemistry of sepsis: role of proteinases, proteinase inhibitors and oxidizing agents. Behring Inst Mitt 1986:79:121-130.
59. Siebeck M, Hoffmann H, Weipert J, Fritz H. Effect of the elastase inhibitor eglin c in porcine endotoxin shock. Circ Shock 1992;36:174-179.
60. Siebeck M, Spannagl M, Hoffmann H, Fink E. Effects of protease inhibitors in experimental septic shock. Agents Actions Suppl 1992;38:421-427.
61. Inauen W, Granger DN, Meininger CJ, et al. Anoxia-reoxygenation-induced, neutrophil-mediated endothelial cell injury: role of elastase. Am J Physiol 1990;259:H925-H931. (Pubitemid 20310500)
62. Zimmerman BJ, Granger DN. Reperfusion-induced leukocyte infiltration: role of elastase. Am J Physiol 1990;259:H390-H394. (Pubitemid 20259412)
63. Pintucci G, Iacoviello L, Castelli MP, et al. Cathepsin G - induced release of PAI-1 in the culture medium of endothelial cells: a new thrombogenic role for polymorphonuclear leukocytes? J Lab Clin Med 1993;122:69-79. (Pubitemid 23206876)
64. Woodman RC, Reinhardt PH, Kanwar S, et al. Effect of human neutrophil elastase (HNE) on neutrophil function in vitro and in inflamed microvessels. Blood 1993;82:2188-2195. (Pubitemid 23294005)
65. Yamamoto J, Ishii I, Okada Y, et al. Effect of leucocyte products on platelet thrombus formation, coagulation and spontaneous thrombolysis, as measured from native human blood, in vitro. Thromb Res 1993;71:281-287. (Pubitemid 23222871)
66. Hansen PR, Stawski G. Neutrophil mediated damage to isolated myocytes after anoxia and reoxygenation. Cardiovasc Res 1994;28:565-569. (Pubitemid 24146183)
67. Totani L, Piccoli A, Pellegrini G, et al. Polymorphonuclear leucocytes enhance release of growth factors by cultured endothelial cells. Arterioscler Thromb 1994;14:125-132.
68. Fritz H, Oppitz KH, Gebhardt M, et al. On the presence of a trypsin-plasmin inhibitor in hirudin. Hoppe Seylers Z Physiol Chem 1969;350:91-92. [Article in German]
69. Fink E, Rehm H, Gippner C, et al. The primary structure of bdellin B-3 from the leech Hirudo medicinalis. Bdellin B-3 is a compact proteinase inhibitor of a "non-classical" Kazal type. It is present in the leech in a high molecular mass form. Biol Chem Hoppe Seyler 1986;367:1235-1242.
70. Seymour JL, Henzel WJ, Nevins B, et al. Decorsin. A potent glycoprotein IIb-IIIa antagonist and platelet aggregation inhibitor from the leech Macrobdella decora. J Biol Chem 1990;265:10143-10147.
71. Mittl PR, Di Marco S, Fendrich G, et al. A new structural class of serine protease inhibitors revealed by the structure of the hirustasin-kallikrein complex. Structure 1997;5:253-264. (Pubitemid 27158731)
72. Dunwiddie CT, Waxman L, Vlasuk GP, Friedman PA. Purification and characterization of inhibitors of blood coagulation factor Xa from hematophagous organisms. Methods Enzymol 1993;223:291-312.
73. Hauptmann J, Kaiser B. Anticoagulant and antithrombotic action of the factor Xa inhibitor antistasin (ATS). Thromb Res 1993;71:169-174. (Pubitemid 23190642)
74. Hauptmann J, Kaiser B. Anticoagulant potential of synthetic and recombinant inhibitors of factor Xa and thrombin in vitro. Blood Coagul Fibrinolysis 1993;4:577-582. (Pubitemid 23236580)
75. Sollner C, Mentele R, Eckerskorn C, Fritz H Sommerhoff CP. Isolation and characterization of hirustasin an anti-stasin type serine proteinase inhibitor from the medicinal leech Hirudo medicinalis. Eur J Biochem 1994; 219: 937-943. (Pubitemid 24050963)
76. Kim DR, Kang KW. Amino acid sequence of piguamerin, an antistasin-type protease inhibitor from the blood sucking leech Hirudo nipponia. Eur J Biochem 1998;254:692-697. (Pubitemid 28308124)
77. Friedrich T, Kroger B, Koerwer R, et al. An isopeptide bond splitting enzyme from Hirudo medicinalis similar to gamma-glutamyl transpeptidase. Eur J Biochem 1998;256:297-302. (Pubitemid 28404791)
78. Orevi M, Rigbi M, Hy-Am E, et al. A potent inhibitor of platelet activating factor from the saliva of the leech Hirudo medicinalis. Prostaglandins 1992;43:483-495.
79. Grumbine NA, Nicholas A. Feature: reviving an ancient therapy to manage chronic pain. Podiatry Today 2003;16:46-53.
80. Chalisova NI, Pennijajnen VP, Baskova IP, et al. The neurite-stimulating activity of components of the salivary gland secretion of the medicinal leech in cultures of sensory neurons. Neurosci Behav Physiol 2003;33:411-414. (Pubitemid 36596522)
81. Nikonov GI, Titova EA, Seleznev KG. Biological activity and pharmacological properties of the anticoagulant complex (hirudin, plasma kallikrein inhibitor, prostaglandin) from the leech Hirudo medicinalis. Biull Eksp Biol Med 1999;128:673-676. [Article in Russian]
82. Baskova IP, Aguejouf OM, Azougagh-Oualane F, et al. Arterial antithrombotic effect of piyavit, the novel pharmacological preparation from the medicinal leech, and of its components, prostanoids and enzyme destabilase. Thromb Res 1995;77:483-492.